Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study

Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study

Objectives Glucocorticoids have anti-inflammatory, transrepression-mediated effects, although adverse events (AEs; transactivation-mediated effects) limit long-term use in patients with rheumatoid arthritis (RA). We evaluated the efficacy and safety of fosdagrocorat (PF-04171327), a dissociated agon...

Full description

Bibliographic Details
Main Authors: Frank Buttgereit, Dorothy McCabe, Eun Bong Lee, Vibeke Strand, Abraham Simon-Campos, Astrid Genet, Brinda Tammara, Ricardo Rojo, Judith Hey-Hadavi
Format: Article
Language:English
Published: BMJ Publishing Group 2019-06-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/5/1/e000889.full

Internet

https://rmdopen.bmj.com/content/5/1/e000889.full

Similar Items